Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Törnblom

Real-World Evidence Effect of Budesonide+formoterol Spiromax on Patients With Asthma and Chronic Obstructive Pulmonary Disease in Sweden

European Clinical Respiratory Journal
2019English

Related publications

Triple Therapy With Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients With Asthma-Chronic Obstructive Pulmonary Disease Overlap

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2020English

Human Medicines European Public Assessment Report (EPAR): DuoResp Spiromax, Budesonide / Formoterol, Pulmonary Disease, Chronic Obstructive,Asthma, Date of Authorisation: 28/04/2014, Revision: 7, Status: Authorised

Case Medical Research
2019English

Long-Term Treatment With Budesonide/Formoterol Attenuates Circulating CRP Levels in Chronic Obstructive Pulmonary Disease Patients of Group D

PLoS ONE
Multidisciplinary
2017English

Sequentially Induced Sputum in Patients With Asthma or Chronic Obstructive Pulmonary Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1999English

Cellular and Cytokine Immunoregulation in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

Mediators of Inflammation
ImmunologyCell Biology
2002English

Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome

Immunology and Allergy Clinics of North America
AllergyImmunology
2016English

Budesonide-Formoterol Reliever Therapy in Asthma

Thorax
PulmonaryRespiratory Medicine
2006English

Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaAs Needed Budesonide-Formoterol Versus Maintenance Budesonide in Mild Asthma

Pediatrics
Child HealthPediatricsPerinatology
2018English

Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler on Exacerbations Versus Formoterol in Chronic Obstructive Pulmonary Disease: The 6-Month, Randomized RISE (Revealing the Impact of Symbicort in Reducing Exacerbations in COPD) Study

Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy